Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DAN93C
|
|||
| Drug Name |
ATA230
|
|||
| Synonyms |
adimlecleucel
Click to Show/Hide
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Cytomegalovirus infection [ICD-11: 1D82] | Clinical trial | [1] | |
| Company |
Atara Biotherapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03010332) An Expanded Access Protocol of ATA230 (Third-Party Donor-Derived Cytomegalovirus-Specific T Cells) for the Treatment of CMV Viremia or Disease in Subjects for Whom There Are No Other Comparable Options. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.